NAPRAPATSENTERET AS
Signals
- Negativ egenkapital 2025 Bokført egenkapital er negativ (−368k kr).
- Ingen revisor Selskapet har ingen registrert revisor. Vanlig for små AS som har valgt bort revisjon, men verdt å merke seg.
NAPRAPATSENTERET AS is registered as a limited company in Oslo, Oslo with organisation number 918563466. The business is classified under traditional, complementary and alternative medicine activities (NACE 86.960). The company was incorporated in 2017. Registered share capital is NOK 30,000, divided into 1000 shares. The company's stated purpose is: “Selskapets virksomhet er behandling av muskler og leddproblemer og andre produkter/tjenester som naturlig hører til dette, herunder å delta i andre selskap med lignende virksomhet, og kjøp og salg av aksjer eller på annen måte gjøre seg interessert i andre foretak.”. The most recent filed accounts, for the 2025 financial year, show NOK 2.6m in revenue and NOK 94,000 in operating profit.
Key figures · 2025
Financial health · 2025
Solidity capped at Weak because equity is below NOK 100,000.
Who owns NAPRAPATSENTERET AS?
NAPRAPATSENTERET AS has 1 registered shareholder:
- ANATOMIX HOLDING AS 100.0%
Frequently asked questions about NAPRAPATSENTERET AS
Who owns NAPRAPATSENTERET AS?
ANATOMIX HOLDING AS is the largest registered owner, with 100.0%.
What is the revenue of NAPRAPATSENTERET AS?
NAPRAPATSENTERET AS had revenue of NOK 2.6m in 2025.
Who is the general manager of NAPRAPATSENTERET AS?
Guy Robert Giltun is registered as general manager of NAPRAPATSENTERET AS.
Where is NAPRAPATSENTERET AS based?
NAPRAPATSENTERET AS has its business address in Oslo.
Source: Biztrac.no · Data from the Brønnøysund Register Centre and the Norwegian Tax Administration · Last updated 03.10.2026.